Listing ID #4830163
Company Information
Ask for more detail from the seller
Contact SupplierWe are leading manufacturer and exporter of pharmaceutical Eltrombopag is a medication that has been developed for certain conditions that lead to thrombocytopenia (abnormally low platelet counts). It is a small molecule agonist of the c-mpl (TpoR) receptor, which is the physiological target of the hormone thrombopoietin. Eltrombopag was discovered as a result of research collaboration between GlaxoSmithKline and Ligand Pharmaceuticals. Designated an orphan drug in the United States and European Union, it is being manufactured and marketed by Novartis under the trade name Promacta in the USA and is marketed as Revolade in the EU. Novartis acquired the drug as a part of its asset swap deal with GlaxoSmithKline
Â
Established in 2013, Athos Chemicals is counted as a reputed name in the region. We are led by Ravi Patel, who is a Partner in the firm. Our company is located in the city of Surat, Gujarat (India) and we offer USA, Africa, Europe, Middle East, and Canada.
Â
Vision
Our vision is to offer the best to clients. We provide important APIs at reasonable prices, and the range is in in accordance with client’s expectations. In today’s highly expensive regulatory environment, we take utmost care of quality. We pay enough attention to all operations and ensure flawless outcomes.
Â
Quality
We are committed towards offering premium quality products. All these pharmaceutical products are formulated under the guidance of experts, and as per the set norms of the industry. While formulating these medicines, we use modern machines and top-quality ingredients. A team of experienced professionals monitor various stages of production, and examine all products on a set of quality parameters.